CORBION NV (CRBN.AS) Stock Fundamental Analysis

AMS:CRBN • NL0010583399

20.86 EUR
-0.04 (-0.19%)
Last: Feb 20, 2026, 07:00 PM
Fundamental Rating

5

Overall CRBN gets a fundamental rating of 5 out of 10. We evaluated CRBN against 66 industry peers in the Chemicals industry. CRBN has only an average score on both its financial health and profitability. CRBN is valued quite cheap, but it does not seem to be growing. This makes CRBN very considerable for value investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year CRBN was profitable.
  • In the past year CRBN had a positive cash flow from operations.
  • Each year in the past 5 years CRBN has been profitable.
  • Each year in the past 5 years CRBN had a positive operating cash flow.
CRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFCRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

  • CRBN's Return On Assets of 4.57% is fine compared to the rest of the industry. CRBN outperforms 71.21% of its industry peers.
  • CRBN has a better Return On Equity (9.14%) than 68.18% of its industry peers.
  • CRBN has a better Return On Invested Capital (9.22%) than 77.27% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CRBN is in line with the industry average of 7.06%.
  • The 3 year average ROIC (6.62%) for CRBN is below the current ROIC(9.22%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.57%
ROE 9.14%
ROIC 9.22%
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
CRBN.AS Yearly ROA, ROE, ROICCRBN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • CRBN has a better Profit Margin (5.12%) than 65.15% of its industry peers.
  • CRBN's Profit Margin has improved in the last couple of years.
  • CRBN has a better Operating Margin (8.70%) than 63.64% of its industry peers.
  • CRBN's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 26.10%, CRBN perfoms like the industry average, outperforming 40.91% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CRBN has declined.
Industry RankSector Rank
OM 8.7%
PM (TTM) 5.12%
GM 26.1%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
CRBN.AS Yearly Profit, Operating, Gross MarginsCRBN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CRBN is creating some value.
  • CRBN has less shares outstanding than it did 1 year ago.
  • CRBN has less shares outstanding than it did 5 years ago.
  • CRBN has a better debt/assets ratio than last year.
CRBN.AS Yearly Shares OutstandingCRBN.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CRBN.AS Yearly Total Debt VS Total AssetsCRBN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • CRBN has an Altman-Z score of 2.86. This is not the best score and indicates that CRBN is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of CRBN (2.86) is better than 63.64% of its industry peers.
  • The Debt to FCF ratio of CRBN is 4.92, which is a neutral value as it means it would take CRBN, 4.92 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of CRBN (4.92) is better than 72.73% of its industry peers.
  • CRBN has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
  • With a Debt to Equity ratio value of 0.39, CRBN perfoms like the industry average, outperforming 56.06% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.92
Altman-Z 2.86
ROIC/WACC1.4
WACC6.58%
CRBN.AS Yearly LT Debt VS Equity VS FCFCRBN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • CRBN has a Current Ratio of 1.21. This is a normal value and indicates that CRBN is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.21, CRBN is doing worse than 77.27% of the companies in the same industry.
  • A Quick Ratio of 0.60 indicates that CRBN may have some problems paying its short term obligations.
  • CRBN has a worse Quick ratio (0.60) than 84.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.6
CRBN.AS Yearly Current Assets VS Current LiabilitesCRBN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

  • CRBN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -68.92%.
  • Measured over the past years, CRBN shows a very strong growth in Earnings Per Share. The EPS has been growing by 49.47% on average per year.
  • CRBN shows a small growth in Revenue. In the last year, the Revenue has grown by 2.95%.
  • The Revenue has been growing slightly by 5.70% on average over the past years.
EPS 1Y (TTM)-68.92%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.24% on average over the next years. This is quite good.
  • Based on estimates for the next years, CRBN will show a decrease in Revenue. The Revenue will decrease by -1.71% on average per year.
EPS Next Y36.96%
EPS Next 2Y22.71%
EPS Next 3Y19.54%
EPS Next 5Y15.24%
Revenue Next Year-2.4%
Revenue Next 2Y-0.19%
Revenue Next 3Y1.19%
Revenue Next 5Y-1.71%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRBN.AS Yearly Revenue VS EstimatesCRBN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B
CRBN.AS Yearly EPS VS EstimatesCRBN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

7

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 18.62, CRBN is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Earnings ratio of CRBN indicates a somewhat cheap valuation: CRBN is cheaper than 71.21% of the companies listed in the same industry.
  • CRBN is valuated rather cheaply when we compare the Price/Earnings ratio to 26.99, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 13.77, which indicates a correct valuation of CRBN.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CRBN indicates a somewhat cheap valuation: CRBN is cheaper than 78.79% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of CRBN to the average of the S&P500 Index (28.06), we can say CRBN is valued rather cheaply.
Industry RankSector Rank
PE 18.62
Fwd PE 13.77
CRBN.AS Price Earnings VS Forward Price EarningsCRBN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRBN indicates a somewhat cheap valuation: CRBN is cheaper than 68.18% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRBN indicates a rather cheap valuation: CRBN is cheaper than 93.94% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.1
EV/EBITDA 8.47
CRBN.AS Per share dataCRBN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CRBN has a very decent profitability rating, which may justify a higher PE ratio.
  • CRBN's earnings are expected to grow with 19.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.5
PEG (5Y)0.38
EPS Next 2Y22.71%
EPS Next 3Y19.54%

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.06%, CRBN has a reasonable but not impressive dividend return.
  • CRBN's Dividend Yield is a higher than the industry average which is at 2.13.
  • Compared to an average S&P500 Dividend Yield of 1.85, CRBN pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.06%

5.2 History

  • The dividend of CRBN has a limited annual growth rate of 5.02%.
Dividend Growth(5Y)5.02%
Div Incr Years1
Div Non Decr Years5
CRBN.AS Yearly Dividends per shareCRBN.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

  • CRBN pays out 56.02% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • CRBN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP56.02%
EPS Next 2Y22.71%
EPS Next 3Y19.54%
CRBN.AS Yearly Income VS Free CF VS DividendCRBN.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M
CRBN.AS Dividend Payout.CRBN.AS Dividend Payout, showing the Payout Ratio.CRBN.AS Dividend Payout.PayoutRetained Earnings

CORBION NV

AMS:CRBN (2/20/2026, 7:00:00 PM)

20.86

-0.04 (-0.19%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A
Earnings (Next)02-26
Inst Owners92.92%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap1.22B
Revenue(TTM)1.30B
Net Income(TTM)66.40M
Analysts78.57
Price Target24.12 (15.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.06%
Yearly Dividend0.71
Dividend Growth(5Y)5.02%
DP56.02%
Div Incr Years1
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.85%
PT rev (3m)5.85%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.26%
EPS NY rev (3m)0.26%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.61%
Valuation
Industry RankSector Rank
PE 18.62
Fwd PE 13.77
P/S 0.94
P/FCF 12.1
P/OCF 7.2
P/B 1.67
P/tB 1.92
EV/EBITDA 8.47
EPS(TTM)1.12
EY5.37%
EPS(NY)1.52
Fwd EY7.26%
FCF(TTM)1.72
FCFY8.26%
OCF(TTM)2.9
OCFY13.88%
SpS22.26
BVpS12.47
TBVpS10.88
PEG (NY)0.5
PEG (5Y)0.38
Graham Number17.72
Profitability
Industry RankSector Rank
ROA 4.57%
ROE 9.14%
ROCE 10.95%
ROIC 9.22%
ROICexc 9.59%
ROICexgc 10.58%
OM 8.7%
PM (TTM) 5.12%
GM 26.1%
FCFM 7.74%
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
ROICexc(3y)7.16%
ROICexc(5y)7.83%
ROICexgc(3y)8.31%
ROICexgc(5y)9.44%
ROCE(3y)7.87%
ROCE(5y)8.47%
ROICexgc growth 3Y0.82%
ROICexgc growth 5Y-11.84%
ROICexc growth 3Y3.78%
ROICexc growth 5Y-8.06%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
F-Score6
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.92
Debt/EBITDA 1.43
Cap/Depr 80.83%
Cap/Sales 5.27%
Interest Coverage 7.23
Cash Conversion 85.5%
Profit Quality 151.21%
Current Ratio 1.21
Quick Ratio 0.6
Altman-Z 2.86
F-Score6
WACC6.58%
ROIC/WACC1.4
Cap/Depr(3y)194.04%
Cap/Depr(5y)192.31%
Cap/Sales(3y)11.51%
Cap/Sales(5y)11.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.92%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
EPS Next Y36.96%
EPS Next 2Y22.71%
EPS Next 3Y19.54%
EPS Next 5Y15.24%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%
Revenue Next Year-2.4%
Revenue Next 2Y-0.19%
Revenue Next 3Y1.19%
Revenue Next 5Y-1.71%
EBIT growth 1Y54.95%
EBIT growth 3Y8.15%
EBIT growth 5Y1.31%
EBIT Next Year128.83%
EBIT Next 3Y37.35%
EBIT Next 5Y26.73%
FCF growth 1Y172.18%
FCF growth 3YN/A
FCF growth 5Y21.2%
OCF growth 1Y119.09%
OCF growth 3Y101.81%
OCF growth 5Y9.98%

CORBION NV / CRBN.AS FAQ

What is the fundamental rating for CRBN stock?

ChartMill assigns a fundamental rating of 5 / 10 to CRBN.AS.


What is the valuation status of CORBION NV (CRBN.AS) stock?

ChartMill assigns a valuation rating of 7 / 10 to CORBION NV (CRBN.AS). This can be considered as Undervalued.


What is the profitability of CRBN stock?

CORBION NV (CRBN.AS) has a profitability rating of 6 / 10.


What is the earnings growth outlook for CORBION NV?

The Earnings per Share (EPS) of CORBION NV (CRBN.AS) is expected to grow by 36.96% in the next year.


How sustainable is the dividend of CORBION NV (CRBN.AS) stock?

The dividend rating of CORBION NV (CRBN.AS) is 6 / 10 and the dividend payout ratio is 56.02%.